
Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …

Cipher Pharmaceuticals has appointed Lynne Bulger as vice president of its medical and clinical affairs whilst also promoting Peter Weiler …
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact

